New Zealand markets closed

Hepion Pharmaceuticals, Inc. (HEPA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.1090-0.0710 (-6.02%)
At close: 04:00PM EDT
1.0352 -0.07 (-6.65%)
After hours: 04:43PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
28,382
35,640
33,269
20,395
11,997
-
Selling general and administrative
8,850
9,618
10,348
10,008
8,149
-
Total operating expenses
37,231
45,258
43,618
30,403
20,146
-
Operating income or loss
-37,231
-45,258
-43,618
-30,403
-20,146
-
Interest expense
11.492
9.465
10.164
8.859
31.229
-
Total other income/expenses net
-4,656
-4,068
-1,456
-2,310
-146.05
-
Income before tax
-41,898
-49,335
-45,084
-32,722
-20,323
-
Income tax expense
-3,378
-409.022
-2,884
0
30.584
-
Income from continuing operations
-38,520
-48,926
-42,200
-32,722
-20,354
-
Net income
-38,520
-48,926
-42,200
-32,722
-20,354
-
Net income available to common shareholders
-38,520
-48,926
-45,338
-32,722
-20,359
-
Basic EPS
-12.42
-
-11.90
-9.40
-42.00
-122.20
Diluted EPS
-12.42
-
-11.90
-9.40
-42.00
-122.20
Basic average shares
3,822
-
3,811
3,515
483.891
102.162
Diluted average shares
3,822
-
3,811
3,515
483.891
102.162